Health Bulletin 11/November/2023 Roshni Dhar11 Nov 2023 2:16 PM ISTHere are the top health stories for the day:NBE grants final opportunity for registration to 2021, 2022 batch traineesThe National Board of...
Ozempic side effects 'well-known', Novo Nordisk argues Ruchika Sharma10 Nov 2023 10:00 AM ISTNovo Nordisk has refuted a Louisiana woman’s claim that her doctors weren’t properly warned of the side effects of the company’s blockbuster drug...
Novo Nordisk to discontinue long-acting insulin Levemir in US Ruchika Sharma9 Nov 2023 5:30 PM IST"Novo Nordisk will phase out, then permanently discontinue Levemir in the U.S. on December 31, 2024," the company said in a statement.
Novo Nordisk, Eli Lilly see insatiable demand for weight loss drugs Ruchika Sharma5 Nov 2023 10:00 AM ISTNovo Nordisk and Eli Lilly both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years - limited only by...
No casual link found between GLP-1 drugs like Novo Nordisk Ozempic, thyroid cancer: EMA Ruchika Sharma29 Oct 2023 12:30 PM ISTThe European Medicines Agency (EMA) has said its safety panel did not find a causal link between popular GLP-1 drugs such as Novo...
Novo Nordisk to stop once-weekly injectable semaglutide kidney outcomes trial Ruchika Sharma10 Oct 2023 11:00 AM IST"Based on the decision to stop the trial at interim, the process of closing the trial will be initiated. To protect the integrity of the trial, Novo...
Novo Nordisk India head eyes 2026 weight-loss drug Wegovy launch Roshni Dhar3 Oct 2023 3:24 PM ISTDanish drugmaker Novo Nordisk aims to bring its blockbuster weight-loss drug Wegovy to India in 2026, after securing regulatory approvals and ensuring...
FDA approve Nedosiran Injection for rare kidney disorder Dr. Kamal Kant Kohli3 Oct 2023 2:00 PM ISTThe US Food and Drug Administration has approved Nedosiran (Rivfloza), a once-monthly RNA interference (RNAi) injection for certain patients with...
Novo Nordisk gets USFDA nod for Rivfloza injection for rare genetic condition Ruchika Sharma3 Oct 2023 11:49 AM ISTRivfloza, the RNAi therapeutic by Novo Nordisk, was developed using the proprietary GalXC RNAi technology platform.
Health Bulletin 2/ October/ 2023 Roshni Dhar2 Oct 2023 3:40 PM ISTHere are the top health stories for the day:MCC releases final result for round 3 of NEET PG, NEET MDS counsellingThe Medical Counselling Committee...
Novo Nordisk eyes to bring blockbuster weight-loss drug Wegovy to India in 2026 Ruchika Sharma1 Oct 2023 1:00 PM ISTNovo charges more than $1300 in the U.S. for a monthly supply and about 300 euros ($317) a month in Germany.
Anti obesity drugs can shrink more than patients Roshni Dhar25 Sept 2023 2:48 PM ISTStarry-eyed venture capitalists love to talk about how promising startups might capture a chunk of a giant total addressable market (TAM). This...
